NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Joe Biden
    United States of America
    COVID-19
    Pakistan
    Russia-Ukraine crisis
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / World News / #NewsBytesExplainer: What is BF.7, Omicron sub-variant triggering China's COVID-19 spurt
    World

    #NewsBytesExplainer: What is BF.7, Omicron sub-variant triggering China's COVID-19 spurt

    #NewsBytesExplainer: What is BF.7, Omicron sub-variant triggering China's COVID-19 spurt
    Written by Prateek Talukdar
    Dec 22, 2022, 10:40 am 3 min read
    #NewsBytesExplainer: What is BF.7, Omicron sub-variant triggering China's COVID-19 spurt
    XBB is the most common variant in India, accounting for 65.6% of all cases in November

    Four cases of Omicron sub-variant BF.7, which is believed to be driving the current spurt of COVID-19 cases in China, were reported in India on Wednesday. It first made headlines in October, when it replaced the dominant variants in the US and Europe. BF.7, which branched out of BA.5, has the strongest infection ability since it is highly transmissible.

    Why does this story matter?

    • BF.7's neutralization resistance is reportedly 4.4 times more than D614G—the original variant which spread worldwide from Wuhan in 2020.
    • In October, BF.7 accounted for over 5% of cases in the US and 7.26% in the UK, though there wasn't any drastic change in the number of hospitalizations.
    • In November, BA.5 lineages accounted for 2.5% of cases in India.

    China's rise in cases due to immunologically naive population: Report

    BF.7 is short for BA.5.2.1.7, a sub-lineage of Omicron's BA.5 sub-variant. BA.4 and BA.5 never took hold in India and the January 2022 wave was driven by BA.1 and BA.2 sub-variants. The reason for its spread in China is not its neutralization resistance or higher transmissibility but the immunologically naive population, as per the Indian Express.

    India paid the price during Delta wave: INSACOG ex-chief

    Indian SARS-CoV-2 Genomics Consortium's (INSACOG) former head, Dr. Anurag Agarwal, said that China was witnessing the "typical Omicron surge" that other countries also faced. He said the Omicron wave looked milder in India as the population was already infected and vaccinated. India "paid the price" during the Delta wave in April-May 2021, and those who survived came out with improved immunity, he added.

    Hong Kong faced similar surge after relaxing norms

    Agarwal said Omicron was largely affecting the elderly and India has a younger population. Hong Kong experienced a similar increase in cases after easing restrictions. Notably, China's rise in cases has followed the relaxing of norms under its zero-COVID-19 policy. He said the countries that remained closed until complete vaccination, such as Australia, New Zealand, and Singapore, didn't suffer as much.

    China developed vaccines before later mutations

    Though China has a vaccination rate of around 90% or 235.5 doses per 100 persons, as per the World Health Organization (WHO), it developed and administered the vaccines to people against the original variant D614G. Since then, the virus mutated many times over, and the Omicron variants are known to dodge the immune responses from current vaccines.

    mRNA vaccine better than 'killed virus' vaccine

    The current vaccines aren't very efficient at neutralizing the Omicron variants but they prevent deaths. Agarwal said that mRNA vaccines, such as those developed by Pfizer and Moderna, are more effective than the 'killed virus' vaccine, as evident from Hong Kong.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Vaccine
    COVID-19
    COVID-19 India
    China

    Latest

    Union Budget 2023-24: Key takeaways for the Indian auto industry Union Budget
    WFH: How to balance your professional and parental duties Children
    Premier League: Major deadline day signings in January transfer window Premier League
    As Murakami announces new book, let's revisit his previous must-reads Books

    Vaccine

    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched COVID-19
    US approves world's first vaccine for honey bees United States of America
    China slams 'distorted' Western reports on COVID-19 response, eases restrictions China
    Delhi: Government centers run out of free COVID-19 booster vaccine Delhi

    COVID-19

    Kerala: Man gets 3 life-terms for raping, impregnating minor daughter Kerala
    Amid global slowdown predictions, IMF calls India 'bright spot' International Monetary Fund
    Have you heard about the travel trends for 2023 yet Travel And Tourism
    COVID-19 outbreak has infected 80% of Chinese population China

    COVID-19 India

    Centre refutes reports on side-effects of COVID-19 vaccines Union Health Ministry
    Centre has no plans to regulate airfares: Jyotiraditya Scindia  Jyotiraditya Scindia
    COVID-19: China-like BF.7 wave unlikely; PM Modi emphasizes following protocols COVID-19
    COVID-19 test mandatory for arrivals from China, 4 other countries COVID-19

    China

    Congress's Jairam Ramesh reacts to S Jaishankar's 'China 1962' remark Congress Party
    India lost access to 26 patrolling points in Ladakh: Report Ladakh
    California: Mass shooting at Chinese New Year event, 9 dead Mass Shooting
    Global recession risk is high, warns World Economic Forum  World Economic Forum

    Love World News?

    Subscribe to stay updated.

    World Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023